• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体疾病的表型变异性(异质性)

Phenotypic variability (heterogeneity) of peroxisomal disorders.

作者信息

Mandel Hanna, Korman Stanley H

机构信息

Metabolic Disease Unit, Department of Pediatrics, Rambam Medical Center, Technion-Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, Haifa, Israel.

出版信息

Adv Exp Med Biol. 2003;544:9-30. doi: 10.1007/978-1-4419-9072-3_2.

DOI:10.1007/978-1-4419-9072-3_2
PMID:14713208
Abstract

Peroxisomes perform a multitude of biosynthetic and catabolic functions, many of which are related to lipid metabolism. Peroxisomal disorders result either from deficiency of a single peroxisomal enzyme or protein, or from a defect in the complex mechanism of peroxisomal biogenesis, resulting in deficiency of several or multiple peroxisomal functions. These can be assessed by a battery of biochemical assays, enabling a biochemical phenotype to be defined that is specific and diagnostic for each of the peroxisomal disorders. Some peroxisomal disorders have unique and specific clinical phenotypes, which may be diagnostic. Others share patterns of clinical abnormalities (particularly neurological dysfunction, craniofacial dysmorphism, skeletal defects, sensory deafness, retinopathy) consistent with defined clinical phenotypes, but with considerable overlap and heterogeneity. To a certain extent, the clinical features of a particular disorder reflect the accumulation or deficiency of specific metabolites. Thus, the same clinical phenotypes may be caused by both single enzyme defects and PBDs. Furthermore, the same defect may present with different clinical phenotypes. In general, the severity of the clinical phenotype correlates with the degree of biochemical dysfunction. The clinical heterogeneity of peroxisomal disorders constitutes a diagnostic challenge demanding a high index of suspicion on the clinician's part.

摘要

过氧化物酶体执行多种生物合成和分解代谢功能,其中许多与脂质代谢有关。过氧化物酶体疾病要么源于单一过氧化物酶体酶或蛋白质的缺乏,要么源于过氧化物酶体生物发生的复杂机制缺陷,导致几种或多种过氧化物酶体功能缺乏。这些可以通过一系列生化检测来评估,从而能够定义一种生化表型,该表型对于每种过氧化物酶体疾病都是特异的且具有诊断性。一些过氧化物酶体疾病具有独特而特异的临床表型,可能具有诊断价值。其他疾病则具有与已定义临床表型一致的临床异常模式(特别是神经功能障碍、颅面部畸形、骨骼缺陷、感觉性耳聋、视网膜病变),但存在相当大的重叠和异质性。在一定程度上,特定疾病的临床特征反映了特定代谢物的积累或缺乏。因此,相同的临床表型可能由单酶缺陷和过氧化物酶体生物合成障碍(PBDs)共同导致。此外,相同的缺陷可能表现出不同的临床表型。一般来说,临床表型的严重程度与生化功能障碍的程度相关。过氧化物酶体疾病的临床异质性对诊断构成了挑战,需要临床医生保持高度的怀疑指数。

相似文献

1
Phenotypic variability (heterogeneity) of peroxisomal disorders.过氧化物酶体疾病的表型变异性(异质性)
Adv Exp Med Biol. 2003;544:9-30. doi: 10.1007/978-1-4419-9072-3_2.
2
Peroxisome biogenesis disorders.过氧化物酶体生物发生障碍
Biochim Biophys Acta. 2006 Dec;1763(12):1733-48. doi: 10.1016/j.bbamcr.2006.09.010. Epub 2006 Sep 14.
3
Peroxisomal disorders.过氧化物酶体病
Curr Opin Pediatr. 1999 Dec;11(6):572-6. doi: 10.1097/00008480-199912000-00017.
4
Lipoprotein[a] is not present in the plasma of patients with some peroxisomal disorders.在一些过氧化物酶体疾病患者的血浆中不存在脂蛋白[a]。
J Lipid Res. 1997 Aug;38(8):1612-9.
5
Defective lipid remodeling of GPI anchors in peroxisomal disorders, Zellweger syndrome, and rhizomelic chondrodysplasia punctata.过氧化物酶体病、Zellweger 综合征和点状软骨发育不良中 GPI 锚的脂质重塑缺陷。
J Lipid Res. 2012 Apr;53(4):653-63. doi: 10.1194/jlr.M021204. Epub 2012 Jan 17.
6
Peroxisomal leukoencephalopathy.过氧化物酶体脑白质营养不良。
Semin Neurol. 2012 Feb;32(1):42-50. doi: 10.1055/s-0032-1306385. Epub 2012 Mar 15.
7
The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder.Zellweger 谱系障碍中线粒体功能障碍的生化基础。
EMBO Rep. 2021 Oct 5;22(10):e51991. doi: 10.15252/embr.202051991. Epub 2021 Aug 5.
8
Human disorders of peroxisome metabolism and biogenesis.人类过氧化物酶体代谢与生物发生紊乱。
Biochim Biophys Acta. 2016 May;1863(5):922-33. doi: 10.1016/j.bbamcr.2015.11.015. Epub 2015 Nov 22.
9
[Phenotype--genotype relationships in peroxisome biogenesis disorders].[过氧化物酶体生物发生障碍中的表型-基因型关系]
No To Shinkei. 2001 May;53(5):411-20.
10
Biochemical markers predicting survival in peroxisome biogenesis disorders.预测过氧化物酶体生物发生障碍患者生存情况的生化标志物。
Neurology. 2002 Dec 10;59(11):1746-9. doi: 10.1212/01.wnl.0000036609.14203.70.

引用本文的文献

1
Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.脑肾上腺白质营养不良中的缩醛磷脂缺乏及其受洛伐他汀的调节作用。
J Neurochem. 2008 Aug;106(4):1766-79. doi: 10.1111/j.1471-4159.2008.05513.x. Epub 2008 Jun 7.
2
Specific entities affecting the craniocervical region: syndromes affecting the craniocervical junction.影响颅颈区域的特定疾病:影响颅颈交界区的综合征。
Childs Nerv Syst. 2008 Oct;24(10):1155-63. doi: 10.1007/s00381-008-0608-6. Epub 2008 Mar 28.
3
A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 degrees C.
一种新的PEX12突变被确定为一种过氧化物酶体生物发生障碍的病因,该障碍具有轻度临床表型、成纤维细胞中轻度生化异常以及即使在40摄氏度时过氧化氢酶免疫荧光模式也呈镶嵌状。
J Hum Genet. 2007;52(7):599-606. doi: 10.1007/s10038-007-0157-y. Epub 2007 May 30.